Search alternatives:
point decrease » point increase (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
point decrease » point increase (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
-
1
DART-ID decreases missing datapoints across runs.
Published 2019“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”
-
2
-
3
-
4
Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae
Published 2025“…It also holds significant potential for point-of-care testing in resource-limited areas.…”
-
5
Point elasticity of demand decreasing price
Published 2020“…Point elasticity of demand decreasing price…”
-
6
-
7
-
8
-
9
Changes in the concentration of VEGF in each group at different time points after injury ().
Published 2023Subjects: -
10
-
11
Changes in the concentration of IL-10 in each group at different time points after injury ().
Published 2023Subjects: -
12
Changes in the concentration of TNF-α in each group at different time points after injury ().
Published 2023Subjects: -
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
SLE decreases risk for hormonal cancers.
Published 2021“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”